Anebulo Pharmaceuticals (214) Ownership - Who Owns Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals (214) Ownership Overview
- 51.73% Other Institutional Investors
- 48.27% Public Companies and Individual Investors
The ownership structure of Anebulo Pharmaceuticals (DE:214) stock is a mix of institutional, retail, and individual investors. Approximately 51.73% of the company’s stock is owned by Institutional Investors, and 48.27% is owned by Public Companies and Individual Investors.
The ownership structure of Anebulo Pharmaceuticals (DE:214) stock is a mix of institutional, retail, and individual investors. Approximately 48.27% of the company’s stock is owned by Institutional Investors, 51.73% is owned by Insiders
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
FAQ
What percentage of Anebulo Pharmaceuticals (DE:214) stock is held by institutional investors?
According to the latest TipRanks data, approximately 51.73% of Anebulo Pharmaceuticals (DE:214) stock is held by institutional investors.
What percentage of Anebulo Pharmaceuticals (DE:214) stock is held by retail investors?
According to the latest TipRanks data, approximately 48.27% of Anebulo Pharmaceuticals (DE:214) stock is held by retail investors.
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.